Showing 7911-7920 of 8647 results for "".
- Pfizer Begins Human Testing for Experimental Coronavirus Vaccine In the UShttps://modernod.com/news/pfizer-begins-human-testing-for-experimental-coronavirus-vaccine-in-the-us/2477710/Pfizer said Tuesday it has begun testing an experimental vaccine to combat the coronavirus in the United States. The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vac
- World Leaders Pledge $8 Billion To Fight COVID-19; US Skips Meetinghttps://modernod.com/news/world-leaders-pledge-8-billion-to-fight-covid-19-us-skips-meeting/2477711/A global alliance responded to calls to fight the coronavirus pandemic on Monday, as world leaders pledged some $8 billion to develop vaccines and treatments to fight COVID-19, according to an NPR
- Icare USA New Confocal Fundus Imaging System and Handheld Tonometerhttps://modernod.com/news/icare-usa-new-confocal-fundus-imaging-system-and-handheld-tonometer/2477707/Icare USA announced the release of two new diagnostic technologies: the Centervue DRSplus confocal fundus imaging system, and the Icare ic200 handheld tonometer for portable measurement of IOP. “We’re excited to introduce clinicians to these new technologies—the disruptive DRSplus platform
- CMS Eases Requirements for COVID-19 Tests, Boosts Payments for Telephonic Visitshttps://modernod.com/news/cms-eases-requirements-for-covid-19-tests-boosts-payments-for-telephonic-visits/2477699/The Trump administration is easing requirements on testing for COVID-19 to make it easier to administer drive-thru and “parking lot” testing facilities, according to a FierceHealthcare
- Kala Pharmaceuticals Resubmits NDA for Eysuvis for Dry Eye Diseasehttps://modernod.com/news/kala-pharmaceuticals-resubmits-nda-for-eysuvis-for-dry-eye-disease/2477696/Kala Pharmaceuticals announced that it has resubmitted its new drug application (NDA) to the FDA for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, a product candidate for the short-term treatment of the signs and symptoms of dry eye disease. Kala believes this application will be c
- More Than 1 Million People Have Recovered From COVID-19 Worldwidehttps://modernod.com/news/more-than-1-million-people-have-recovered-from-covid-19-worldwide/2477691/More than 1 million people around the world have recovered from COVID-19, according to data collected by Johns Hopkins University, as
- Gilead ‘Moving Very Quickly’ With FDA on Possible Coronavirus Use, CEO Sayshttps://modernod.com/news/remdesivir-maker-moving-very-quickly-with-fda-on-possible-coronavirus-use-ceo-says/2477690/The maker of Remdesivir, an experimental drug for treatment of the coronavirus, is moving very quickly with the FDA for authorization to get the drug to patients, the CEO of the company, Gilead Sciences, said Friday,
- Certain Hospital Systems Eye a Restart of Elective Procedures Canceled Due to COVID-19https://modernod.com/news/certain-hospital-systems-eye-a-restart-of-elective-procedures-canceled-due-to-covid-19/2477687/Hospital systems are taking the first steps toward reviving elective procedures that have been canceled due to the COVID-19 pandemic, but major concerns about safety and patient confidence remain, according to a FierceHealthcare
- Higher Rates of COVID-19 Infection and Death for People With Parkinson Diseasehttps://modernod.com/news/higher-rates-of-covid-19-infection-and-death-for-people-with-parkinson-disease/2477683/A paper accepted for publication in Movement Disorders suggests that people with Parkinson disease (PD) with longer disease duration (mean 12.7 years) may be more susceptible to infection with the SARS-CoV2 virus (COVID-19), according to an
- A Next-Generation Coronavirus Test Raises Hopes And Concernshttps://modernod.com/news/a-next-generation-coronavirus-test-raises-hopes-and-concerns/2477679/States clamoring for coronavirus tests in recent weeks have been talking about two different types, according to an NPR report. First, there’s a PCR test